Discovery of new drug target modifiying the function of blood-brain barrier and blood-nerve barrier
Project/Area Number |
18K07526
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 52020:Neurology-related
|
Research Institution | Yamaguchi University |
Principal Investigator |
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 自己免疫性神経疾患 / 血液脳関門 / GRP78抗体 / 視神経脊髄炎 / 傍腫瘍性小脳変性症 / 血液神経関門 / 新規抗体製剤開発 / 細胞モデル / 神経免疫疾患 / 自己免疫性ニューロパチー |
Outline of Final Research Achievements |
Objective: The purpose of this project is to develop the assay for identifying the antigen against IgG from the patients with neuro-inflammatory disorders, which cause the BBB disruption using our human in vitro BBB model. Methods: We identified IgG from patients with the neuro-inflammatory disease, which induced NF-κB p65 nuclear translocation in human brain microendothelial cell lines (TY10). We developed the novel assay to detect cell-surface antigen against IgG from the neuro-inflammatory disease. Results: IgGs from paraneoplastic cerebellar degeneration (PCD) with Lambert-Eaton myasthenic syndrome (LEMS) [LEMS-PCD] shows the most ability to give rise to nuclear translocation of NF-κB p65. We detected glucose-regulated protein (GRP)78 autoantibodies in the IgG of LEMS-PCD. Conclusions: We identified GRP78 autoantibodies from LEMS-PCD patients having biological effects on BBB-endothelial cells.
|
Academic Significance and Societal Importance of the Research Achievements |
傍腫瘍性小脳変性症を合併したランバート・イートン筋無力症の発症機序が明らかとなった.GRP78は癌細胞とBBB構成内皮細胞の細胞表面に多く発現しており,細胞表面に発現するGRP78はNF-κBシグナル活性に関与する.さらに,担癌患者では血中にGRP78抗体が検出されることが報告されている.傍腫瘍性小脳変性症を合併したランバート・イートン筋無力症発症の病態機序として,GRP78とP/Q型VGCCは癌細胞表面に発現しており,腫瘍との交差免疫により産生されたGRP78抗体によるBBB破綻が,同じ機序より産生されたP/Q型VGCC抗体の脳内流入を促進し小脳機能障害を惹起する可能性が考えられた.
|
Report
(4 results)
Research Products
(27 results)
-
-
-
-
-
-
-
-
-
-
[Journal Article] GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.2019
Author(s)
Shimizu F, Takeshita Y, Sano Y, Hamamoto Y, Shiraishi H, Sato T, Yoshimura S, Maeda T, Fujikawa S, Nishihara H, Kitanosono H, Tsujino A, Motomura M, Kanda T.
-
Journal Title
Brain.
Volume: 142
Issue: 8
Pages: 2253-2264
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.2019
Author(s)
Shimizu F, Oishi M, Sawai S, Beppu M, Misawa S, Matsui N, Miyashiro A, Maeda T, Takeshita Y, Nishihara H, Sano Y, Sato R, Kaji R, Kuwabara S, Kanda T.
-
Journal Title
J Neurol Neurosurg Psychiatry
Volume: 90
Issue: 4
Pages: 444-450
DOI
NAID
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] MOG抗体関連疾患での血液脳関門破綻メカニズムの解明2020
Author(s)
清水 文崇, 小川 諒, 原 佳那子, 門野 ちひろ, 高橋 利幸, 竹下 幸男, 三須 建郎, 佐野 泰照, 前田 敏彦, 中島 一郎, 藤原 一男, 神田 隆
Organizer
第32回日本神経免疫学会学術集会
Related Report
-
-
-
-
[Presentation] Blood-brain barrier-activation in anti-myelin oligodendrocyte glycoprotein antibody associated disorders.2019
Author(s)
Fumitaka Shimizu, Ryo Ogawa, Kanako Hara, Toshiyuki Takahashi, Yukio Takeshita, Tatsuro Misu, Yasuteru Sano, Toshihiko Maeda, Susumu Fujikawa, Ichiro Nakashima, Kazuo Fujihara, Takashi Kanda.
Organizer
EctriMS 2019
Related Report
Int'l Joint Research
-
[Presentation] Blood-brain barrier-activation in anti-myelin oligodendrocyte glycoprotein antibody associated disorders.2019
Author(s)
Fumitaka Shimizu, Ryo Ogawa, Kanako Hara, Toshiyuki Takahashi, Yukio Takeshita, Tatsuro Misu, Yasuteru Sano, Toshihiko Maeda, Susumu Fujikawa, Ichiro Nakashima, Kazuo Fujihara, Takashi Kanda.
Organizer
Sendai Conference
Related Report
-
-
-
-
-